Cancer genome analysis

A landscape seen from many angles

Henrik Edgren, Maija Wolf, Olli Kallioniemi, Matthias Nees (Corresponding Author)

Research output: Contribution to journalArticleScientific

Abstract

Somatic mutations and copy number alterations are the basis for cancer development and progression, and their identification is crucial for the development of novel diagnostics and therapies. Identification of somatic alterations has been greatly sped up by recent technological progresses, such as CGH and SNP arrays, and high-throughput DNA sequencing. An immense set of genomic data will be available in the near future. It will be mandatory to overlay and integrate multiple levels of genomic and functional information, aiming for the bigger picture of cancer biology. The ultimate goal will be a detailed understanding of pathways and mechanisms altered in cancer, leading the way to improved therapeutic strategies.
Original languageEnglish
Pages (from-to)269-276
JournalDrug Discovery Today: Disease Mechanisms
Volume4
Issue number4
DOIs
Publication statusPublished - 2007
MoE publication typeB1 Article in a scientific magazine

Fingerprint

Genome
High-Throughput Nucleotide Sequencing
Neoplasms
Single Nucleotide Polymorphism
Mutation
Therapeutics
Datasets

Cite this

Edgren, Henrik ; Wolf, Maija ; Kallioniemi, Olli ; Nees, Matthias. / Cancer genome analysis : A landscape seen from many angles. In: Drug Discovery Today: Disease Mechanisms. 2007 ; Vol. 4, No. 4. pp. 269-276.
@article{6783c44945534de78a8d5b16f6baae43,
title = "Cancer genome analysis: A landscape seen from many angles",
abstract = "Somatic mutations and copy number alterations are the basis for cancer development and progression, and their identification is crucial for the development of novel diagnostics and therapies. Identification of somatic alterations has been greatly sped up by recent technological progresses, such as CGH and SNP arrays, and high-throughput DNA sequencing. An immense set of genomic data will be available in the near future. It will be mandatory to overlay and integrate multiple levels of genomic and functional information, aiming for the bigger picture of cancer biology. The ultimate goal will be a detailed understanding of pathways and mechanisms altered in cancer, leading the way to improved therapeutic strategies.",
author = "Henrik Edgren and Maija Wolf and Olli Kallioniemi and Matthias Nees",
year = "2007",
doi = "10.1016/j.ddmec.2008.05.003",
language = "English",
volume = "4",
pages = "269--276",
journal = "Drug Discovery Today: Disease Mechanisms",
issn = "1740-6765",
publisher = "Elsevier",
number = "4",

}

Cancer genome analysis : A landscape seen from many angles. / Edgren, Henrik; Wolf, Maija; Kallioniemi, Olli; Nees, Matthias (Corresponding Author).

In: Drug Discovery Today: Disease Mechanisms, Vol. 4, No. 4, 2007, p. 269-276.

Research output: Contribution to journalArticleScientific

TY - JOUR

T1 - Cancer genome analysis

T2 - A landscape seen from many angles

AU - Edgren, Henrik

AU - Wolf, Maija

AU - Kallioniemi, Olli

AU - Nees, Matthias

PY - 2007

Y1 - 2007

N2 - Somatic mutations and copy number alterations are the basis for cancer development and progression, and their identification is crucial for the development of novel diagnostics and therapies. Identification of somatic alterations has been greatly sped up by recent technological progresses, such as CGH and SNP arrays, and high-throughput DNA sequencing. An immense set of genomic data will be available in the near future. It will be mandatory to overlay and integrate multiple levels of genomic and functional information, aiming for the bigger picture of cancer biology. The ultimate goal will be a detailed understanding of pathways and mechanisms altered in cancer, leading the way to improved therapeutic strategies.

AB - Somatic mutations and copy number alterations are the basis for cancer development and progression, and their identification is crucial for the development of novel diagnostics and therapies. Identification of somatic alterations has been greatly sped up by recent technological progresses, such as CGH and SNP arrays, and high-throughput DNA sequencing. An immense set of genomic data will be available in the near future. It will be mandatory to overlay and integrate multiple levels of genomic and functional information, aiming for the bigger picture of cancer biology. The ultimate goal will be a detailed understanding of pathways and mechanisms altered in cancer, leading the way to improved therapeutic strategies.

U2 - 10.1016/j.ddmec.2008.05.003

DO - 10.1016/j.ddmec.2008.05.003

M3 - Article

VL - 4

SP - 269

EP - 276

JO - Drug Discovery Today: Disease Mechanisms

JF - Drug Discovery Today: Disease Mechanisms

SN - 1740-6765

IS - 4

ER -